OCS Oculis Holding AG - Ordinary shares
NASDAQ · Pharmaceuticals · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Mar 4, 2026
$8.73
· of 52w range
· above low
· to high
$8.5352w low
$34.4852w high
P/E
-10.6
EPS
$-1.89
your badges
52W Range
$9–$34
Analyst Rating
STRONG BUY
Price Target
$37
P/E
-10.6
ROE
-73.5%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
OCS Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$8.73
P/E
-10.6
EPS
$-1.89
ROE
-73.5%
52W Range
$9–$34
OCS Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
EPS$-1.892020-12-31 → 2025-12-31
Free Cash Flow$-67M2022-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | OCS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -10.65Y avg ≈-5.8 | ≈-5.8 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | OCS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -55.5%5Y avg ≈-81.8% | ≈-81.8% | · | · | |
| ROE | -73.5%5Y avg ≈1009.7% | ≈1009.7% | · | · | |
| ROIC | -41.6%5Y avg ≈-48.6% | ≈-48.6% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | OCS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio | 6.05Y avg ≈3.9 | ≈3.9 | · | · | |
| Quick Ratio | 2.25Y avg ≈1.6 | ≈1.6 | · | · | |
| Interest Coverage | -98.05Y avg ≈-218.4 | ≈-218.4 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
1.8%
Next Report
Nov 05, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 6, 2026 | $-0.16 | $-0.41 | 60.7% |
| March 31, 2026 | May 7, 2026 | $-0.49 | $-0.42 | -15.8% |
| Dec. 31, 2025 | $-0.42 | $-0.43 | 1.6% | |
| Sept. 30, 2025 | $-0.32 | $-0.43 | 25.3% | |
| June 30, 2025 | $-0.49 | $-0.47 | -4.5% | |
| March 31, 2025 | $-0.69 | $-0.44 | -56.2% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| R&D Expense | $57M | $52M | $29M | $22M | $10M | |
| SG&A Expense | $26M | $22M | $17M | $11M | $5M | |
| Operating Income | $-82M | $-73M | $-81M | $-32M | $-13M | |
| Interest Expense | $833.0K | $639.0K | $1M | $6M | $5M | |
| Interest Income | $2M | $2M | $1M | $126.0K | $21.0K | |
| Pretax Income | $-99M | $-86M | $-89M | $-39M | $-19M | |
| Income Tax | $-186.0K | $-160.0K | $107.0K | $55.0K | $27.0K | |
| Net Income | $-99M | $-86M | $-89M | $-39M | $-19M | |
| EPS (Basic) | $-1.89 | $-2.12 | $-2.97 | $-11.32 | $-5.84 | |
| EPS (Diluted) | $-1.89 | $-2.12 | $-2.97 | $-11.32 | $-5.84 | |
| Shares (Basic) | 52,243,100 | 40,406,551 | 29,899,651 | 2,989,434 | 2,777,589 | |
| Shares (Diluted) | 52,243,100 | 40,406,551 | 29,899,651 | 2,989,434 | 2,777,589 | |
| EBITDA | $-82M | $-73M | $-81M | $-32M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $81M | $28M | $38M | $20M | $46M | |
| Current Assets | $219M | $105M | $101M | $24M | $48M | |
| PP&E (Net) | $534.0K | $385.0K | $288.0K | $365.0K | $431.0K | |
| Intangibles | $13M | $13M | $12M | $12M | $9M | |
| Total Assets | $236M | $120M | $114M | $37M | $58M | |
| Accounts Payable | $2M | $6M | $8M | $4M | $824.0K | |
| Current Liabilities | $37M | $44M | $19M | $12M | $4M | |
| Total Liabilities | $40M | $47M | $21M | $135M | $119M | |
| Retained Earnings | $-385M | $-286M | $-200M | $-111M | $-72M | |
| Stockholders' Equity | $196M | $73M | $94M | $-98M | $-61M |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $-66M | $-49M | $-55M | $-25M | $-14M | |
| CapEx | $301.0K | $230.0K | $48.0K | $65.0K | $28.0K | |
| Investing Cash Flow | $-61M | $-16M | $-53M | $-4M | $-28.0K | |
| Financing Cash Flow | $187M | $54M | $130M | $2M | $55M | |
| Free Cash Flow | $-67M | $-48M | $-54M | $-25M | · | |
| Levered FCF | $-67M | $-48M | $-55M | $-25M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| ROA | -55.5% | -73.1% | -117.3% | -81.4% | · | |
| ROE | -73.5% | -102.7% | 4166.2% | 48.7% | · | |
| ROIC | -41.6% | -99.6% | -86.2% | 33.1% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 6.0 | 2.4 | 5.3 | 2.0 | · | |
| Quick Ratio | 2.2 | 0.6 | 2.0 | 1.6 | · | |
| Interest Coverage | -98.0 | -114.6 | -61.4 | -599.6 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash Flow / Share | $-1.27 | $-1.18 | $-1.80 | $-8.39 | · | |
| EPS (TTM) | $-1.89 | $-2.12 | $-2.97 | $-11.32 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-99M | $-86M | $-89M | $-39M | · | |
| P/E | -10.6 | -8.0 | -3.8 | -0.9 | · | |
| Earnings Yield | -9.5% | -12.5% | -26.5% | -112.1% | · |
No quarterly filings for OCS
We don't have SEC filings for this ticker yet.
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Income | $-99M | $-86M | $-89M | $-39M | $-19M |
| Diluted EPS | $-1.89 | $-2.12 | $-2.97 | $-11.32 | $-5.84 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 6.0 | 2.4 | 5.3 | 2.0 | · |
| Quick Ratio | 2.2 | 0.6 | 2.0 | 1.6 | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-67M | $-48M | $-54M | $-25M | · |
Institutional owners (13F) 63 filers · $382.2M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
63
Value held
$382.2M
New positions
24
Exited positions
18
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 24 (+1 vs prior Q) | 18 (+11 vs prior Q) | 23 (+12 vs prior Q) | 9 (-2 vs prior Q) | +3.2M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| EQT Fund Management S.a r.l. | $96,400,578 | 6,950,294 | 25.22% | Shares |
| Gildi - lifeyrissjodur | $64,316,401 | 2,430,401 | 16.83% | Shares |
| Aberdeen Group plc | $29,956,551 | 2,159,809 | 7.84% | Shares |
| MILLENNIUM MANAGEMENT LLC | $28,329,017 | 2,042,467 | 7.41% | Shares |
| Pivotal bioVenture Partners Investment Advisor LLC | $20,891,688 | 1,506,250 | 5.47% | Shares |
| CITADEL ADVISORS LLC | $13,692,519 | 987,204 | 3.58% | Shares |
| BRAIDWELL LP | $11,570,118 | 834,183 | 3.03% | Shares |
| PERCEPTIVE ADVISORS LLC | $11,218,430 | 808,827 | 2.93% | Shares |
| Saturn V Capital Management LP | $9,499,286 | 684,880 | 2.49% | Shares |
| SR One Capital Management, LP | $8,890,975 | 641,022 | 2.33% | Shares |
| Siren, L.L.C. | $8,668,750 | 625,000 | 2.27% | Shares |
| AMERIPRISE FINANCIAL INC | $8,598,318 | 619,922 | 2.25% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $7,490,577 | 540,056 | 1.96% | Shares |
| PFM Health Sciences, LP | $6,047,903 | 436,042 | 1.58% | Shares |
| FRANKLIN RESOURCES INC | $6,029,996 | 434,751 | 1.58% | Shares |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $5,533,853 | 398,980 | 1.45% | Shares |
| MARSHALL WACE, LLP | $5,476,986 | 394,880 | 1.43% | Shares |
| Nan Fung Group Holdings Ltd | $4,168,837 | 300,565 | 1.09% | Shares |
| Qube Research & Technologies Ltd | $3,635,507 | 262,113 | 0.95% | Shares |
| MORGAN STANLEY | $3,121,902 | 225,083 | 0.82% | Shares |
| Point72 Asset Management, L.P. | $3,056,990 | 220,403 | 0.80% | Shares |
| Alyeska Investment Group, L.P. | $2,861,825 | 206,332 | 0.75% | Shares |
| Woodline Partners LP | $2,790,644 | 201,200 | 0.73% | Shares |
| Y-Intercept (Hong Kong) Ltd | $2,663,262 | 192,016 | 0.70% | Shares |
| UBS Group AG | $2,530,096 | 182,415 | 0.66% | Shares |
| Trexquant Investment LP | $2,097,532 | 151,228 | 0.55% | Shares |
| Compagnie Lombard Odier SCmA | $1,462,661 | 105,455 | 0.38% | Shares |
| GOLDMAN SACHS GROUP INC | $963,993 | 69,502 | 0.25% | Shares |
| Balyasny Asset Management L.P. | $909,983 | 65,608 | 0.24% | Shares |
| Squarepoint Ops LLC | $854,461 | 61,605 | 0.22% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $849,176 | 61,224 | 0.22% | Shares |
| ALPS ADVISORS INC | $804,724 | 58,019 | 0.21% | Shares |
| BOOTHBAY FUND MANAGEMENT, LLC | $782,143 | 56,391 | 0.20% | Shares |
| CITADEL ADVISORS LLC | $615,828 | 44,400 | 0.16% | Call option |
| BANK OF AMERICA CORP /DE/ | $609,975 | 43,978 | 0.16% | Shares |
| XTX Topco Ltd | $597,742 | 43,096 | 0.16% | Shares |
| Jump Financial, LLC | $551,097 | 39,733 | 0.14% | Shares |
| TUDOR INVESTMENT CORP ET AL | $430,261 | 31,021 | 0.11% | Shares |
| Virtus Investment Advisers, LLC | $409,220 | 29,504 | 0.11% | Shares |
| Persistent Asset Partners Ltd | $355,127 | 25,604 | 0.09% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $348,137 | 25,100 | 0.09% | Call option |
| STATE STREET CORP | $327,013 | 23,577 | 0.09% | Shares |
| JPMORGAN CHASE & CO | $325,234 | 24,846 | 0.09% | Shares |
| NORTHERN TRUST CORP | $286,041 | 20,623 | 0.07% | Shares |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | $239,618 | 17,276 | 0.06% | Shares |
| Marble Bar Asset Management LLP | $205,359 | 14,806 | 0.05% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $177,536 | 12,800 | 0.05% | Put option |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $171,031 | 12,331 | 0.04% | Shares |
| JANE STREET GROUP, LLC | $156,148 | 11,258 | 0.04% | Shares |
| Quantbot Technologies LP | $73,775 | 5,319 | 0.02% | Shares |
OCS Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 15 analysts
BUY
Median target
$38.95
+346.1%
7 46.7%
Strong Buy
7 46.7%
Buy
1 6.7%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
10 analysts · 2026-10-02Mean target $36.63 +319.6%
← Below all targets
Current price $8.73
Low$19.59
Mean$36.63
High$43.82
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F filed Mar 4, 2026